Antibodies, Proteins, Enzymes for drug discovery and molecular diagnostics

Overview:                                                                         LINK to ELISA's

  • ADAMTS
  • HtrAs
  • MMPs
  • Elastase
  • Cathepsins
  • Aminopeptidases
  • Cysteinproteinases
  • Zymography Control for drug discovery and
  • Inhibitors for drug discovery and molecular diagnostics
  • Substrates for drug discovery and molecular diagnostics
  • Antibodies for drug discovery and molecular diagnostics
  • Antibodies for mycotoxins, vitamins, hormones and drugs

Details:

Enzymes for drug discovery and molecular diagnostics

MMPs

ADAMTS

HtrAs

Elastase

Cathepsins

Aminopeptidases

Cysteinproteinases

Kinase

Bacterial Proteases

Zymography Control for drug discovery

Inhibitors for drug discovery and molecular diagnostics

Substrates for drug discovery and molecular diagnostics

Antibodies for drug discovery and molecular diagnostics

Antibodies for mycotoxins, vitamins, hormones and drugs

BioTeZ GmbH

Die BioTeZ Berlin-Buch GmbH ist ein Biotechnologie-Unternehmen und wurde 1992 gegründet. BioTeZ ist Partner der Forschung, der Pharmaindustrie und der Labordiagnostik.

  • Biodiagnostika
  • Oligonukleotide
  • Markierte Biomoleküle

Kontakt

BioTeZ Berlin Buch GmbH
Robert-Rössle-Strasse 10, Haus D 72
13125 Berlin - Germany

Tel: +49 30-9489-2130
Fax: +49 30-9494-509
E-Mail: info@biotez.de
www.biotez.de

Events

Meet BioTeZ at MEDICA, 13-16 Nov. 2017, Düsseldorf. Get Information about diagnostics and biotechnological services we offer: Therapeutic Drug Monitoring, Mycotoxin and Vitamin Analysis, Oligonucleotides, Human Proteases Research, Streptavidin Coatings


Biologics and Biosimilars Congress 2017 BerlinBioTeZ will present the latest research results from collaboration projects at the 3rd Biologics and Biosimilars Congress (6-7 March 2017); Summarizing outcomes of therapeutic drug monitoring studies with Omalizumab/IgE, Adalimumab/TNF and provide insights into Alirocumab, Evolocumab/PCSK9 recoveryELISA projects